Allergens for the diagnosis of allergies through functional tests (Q10160): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item) |
(Removed claim: co-financing rate (P837): 66.4599999728456 percent) |
||||||
Property / co-financing rate | |||||||
| |||||||
Property / co-financing rate: 66.4599999728456 percent / rank | |||||||
Revision as of 14:38, 19 March 2020
Project in Czech Republic financed by DG Regio
Language | Label | Description | Also known as |
---|---|---|---|
English | Allergens for the diagnosis of allergies through functional tests |
Project in Czech Republic financed by DG Regio |
Statements
10,279,419.37 Czech koruna
0 references
15,467,077.0 Czech koruna
0 references
1 January 2016
0 references
30 June 2019
0 references
EXBIO Praha, a.s.
0 references
25250
0 references
Projekt je zaměřen na vývoj ucelené řady prototypů lyofilizovaných alergenových extraktů a rekombinantních alergenních komponent pro in vitro diagnostické použití. Novost a unikátnost prototypů tkví ve vlastní technologii lyofilizace alergenů do podoby jednotestového balení každého nového produktu. Lyofilizované alergeny jsou určeny pro cílenou in vitro diagnostiku alergických reakcí pomocí analytických souprav umožňujících sledování specifických buněčných dějů metodou průtokové cytometrie. a. (Czech)
0 references
The project aims at developing a coherent range of lyophilised allergenic extracts and recombinant allergenic components for in vitro diagnostic use. The novelty and uniqueness of prototypes lie in their technology of lyophilisation of allergens in the form of a single-test packaging for each new product. Lyophilised allergens are intended for targeted in vitro diagnostics of allergic reactions by means of analytical kits allowing the tracking of specific cell events by flow cytometric. a. (English)
0 references
Identifiers
CZ.01.1.02/0.0/0.0/15_019/0001057
0 references